Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - February 09.09.2026 GFEB.LN IE000X8M8M80 700,002.00 USD 27,971,145.08 39.959 ...
-
Codestrap Names Wes Kapsa Chief Revenue Officer as Enterprise AI Customers Recognize Need to Break Through Architectural Wall
SAN FRANCISCO--(BUSINESS WIRE)--Codestrap – a pioneering software development company that delivers specialized solutions to enterprise customers without the cost, risk, and human displacement common to the industry, today announced the appointment of Wes Kapsa as Chief Revenue Officer. The strategic hire comes as enterprise AI adoption grapples with real limits on cost, consistency and risk, and as demand grows from Fortune 500 companies in regulated and non-regulated industries for an approac...
-
Nu Takes Next Step in International Expansion With Launch in the United States and introduction of Nu Global
MIAMI--(BUSINESS WIRE)--Nu (NYSE: NU), the largest digital bank in Latin America, announces the start of operations in the United States with the launch of a full suite of financial products designed for customers' everyday banking needs. In addition to the U.S. launch, Nu also introduces Nu Global, a multi-currency digital account for people with global lives, that allows fee-free, fast money movement across more than 35 countries. These products will be available beginning today; users can si...
-
ABIONYX Pharma franchit une nouvelle étape clé dans l’industrialisation de CER-001 en concluant un partenariat stratégique avec TEXCELL (ABL Diagnostics) dans la sécurité et clairance virales des produits biologiques
TOULOUSE, France & FULLERTON, Calif.--(BUSINESS WIRE)--Regulatory News: ABIONYX Pharma, (FR0012616852 – ABNX – éligible PEA PME), société biopharmaceutique de nouvelle génération qui développe des thérapies innovantes dans le sepsis et les soins intensifs, fondées sur une plateforme technologique exclusive basée sur l’apoA-I, annonce la conclusion d’un partenariat stratégique avec TEXCELL , division de la société ABL Diagnostics, pour la sécurité et la clairance virales de son développement bio...
-
ABIONYX Pharma Reaches Another Key Milestone in the Industrialization of CER-001 by Entering into a Strategic Partnership with TEXCELL (ABL Diagnostics) for the Viral Safety and Clearance of Biologics
TOULOUSE, France & FULLERTON, Calif.--(BUSINESS WIRE)--Regulatory News: ABIONYX Pharma (FR0012616852 - ABNX - PEA PME eligible), a next-generation biopharmaceutical company developing innovative therapies for sepsis and critical care based on a proprietary apoA-I-based technology platform, announces the establishment of a strategic partnership with TEXCELL, a division of ABL Diagnostics, for the viral safety and clearance testing of its biopharmaceutical development. This collaboration marks a...
-
Stensul advances enterprise marketing toward AI-run campaigns
NEW YORK--(BUSINESS WIRE)--Stensul advances AI-run enterprise campaigns with expanded MCP, Figma module creation, and automated QA within approved controls....
-
Turning Up the Heat: ProAmpac Helps Power Circle K’s Flamin’ Hot® Boneless Chicken Wings Launch
CINCINNATI--(BUSINESS WIRE)--ProAmpac, a global leader in flexible packaging and material science, is proud to announce its role in supporting Circle K's launch of Flamin' Hot® Boneless Chicken Wings, created in partnership with PepsiCo/Frito-Lay. Designed to address key challenges in hot food packaging, ProAmpac's custom fiber-based tray helps maintain food quality, improve shelf appeal, and enhance the consumer experience. Circle K sought a better way to merchandise its Flamin’ Hot® Boneless...
-
Deadline Soon: Beta Bionics, Inc. (BBNX) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming November 3, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ: BBNX) securities between July 30, 2025 and February 24, 2026, inclusive (the “Class Period”).IF YOU ARE AN INVESTOR WHO LOST MONEY ON BETA BIONICS, INC. (BBNX), CLICK HERE TO PARTICIPATE IN THE...
-
Kotter Launches The Lead Team Catalyst, a New Consulting Product Designed to Drive Transformation Impact and Fast ROI for Leadership Teams
BOSTON--(BUSINESS WIRE)--Kotter, the global leader in organizational adaptability and transformation, announced the launch of The Lead Team Catalyst, a new leadership product....
-
Law Offices of Frank R. Cruz Encourages Papa John’s International, Inc. (PZZA) Shareholders To Inquire About Securities Fraud Class Action
LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages Papa John’s International, Inc. (PZZA) Shareholders To Inquire About Securities Fraud Class Action...